Diversity in Notch ligand-receptor signaling interactions
eLife · 03.01.2025 · 12
DOI: 10.7554/elife.91422 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 03.01.2025. Verfasst von Rachael Kuintzle und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States. Hauptthemen laut MEDLINE: Signal Transduction, Calcium-Binding Proteins, Intercellular Signaling Peptides and Proteins, Jagged-1 Protein. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The Notch signaling pathway uses families of ligands and receptors to transmit signals to nearby cells. These components are expressed in diverse combinations in different cell types, interact in a many-to-many fashion, both within the same cell (in cis) and between cells (in trans), and their interactions are modulated by Fringe glycosyltransferases. A fundamental question is how the strength of Notch signaling depends on which pathway components are expressed, at what levels, and in which cells. Here, we used a quantitative, bottom-up, cell-based approach to systematically characterize trans-activation, cis-inhibition, and cis-activation signaling efficiencies across a range of ligand and Fringe expression levels in Chinese hamster and mouse cell lines. Each ligand (Dll1, Dll4, Jag1, and Jag2) and receptor variant (Notch1 and Notch2) analyzed here exhibited a unique profile of interactions, Fringe dependence, and signaling outcomes. All four ligands were able to bind receptors in cis and in trans, and all ligands trans-activated both receptors, although Jag1-Notch1 signaling was substantially weaker than other ligand-receptor combinations. Cis-interactions were predominantly inhibitory, with the exception of the Dll1- and Dll4-Notch2 pairs, which exhibited cis-activation stronger than trans-activation. Lfng strengthened Delta-mediated trans-activation and weakened Jagged-mediated trans-activation for both receptors. Finally, cis-ligands showed diverse cis-inhibition strengths, which depended on the identity of the trans-ligand as well as the receptor. The map of receptor-ligand-Fringe interaction outcomes revealed here should help guide rational perturbation and control of the Notch pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States.
- Howard Hughes Medical Institute, California Institute of Technology, Pasadena, United States.
ORCID-Profile: Rachael Kuintzle, Leah A Santat, Michael B Elowitz
Förderung
- NICHD NIH HHS
- NIH HHS
- National Institutes of Health
- Howard Hughes Medical Institute
Zitieren
APA
Kuintzle, R., Santat, L. A., & Elowitz, M. B. (2025). Diversity in Notch ligand-receptor signaling interactions. eLife, 12. https://doi.org/10.7554/elife.91422
Vancouver
Kuintzle R, Santat LA, Elowitz MB. Diversity in Notch ligand-receptor signaling interactions. eLife. 2025;12. doi:10.7554/elife.91422
BibTeX
@article{Kuintzle2025,
author = {Kuintzle, Rachael and Santat, Leah A and Elowitz, Michael B},
title = {Diversity in Notch ligand-receptor signaling interactions},
journal = {eLife},
year = {2025},
volume = {12},
doi = {10.7554/elife.91422}
}
EUVIMED